# Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization

> **NCT00209547** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 110 (—)

## Conditions studied

- Angioplasty
- Coronary Catheterization

## Interventions

- **DRUG:** fospropofol disodium

## Key facts

- **NCT ID:** NCT00209547
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 110 (—)
- **Last updated:** 2008-11-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209547, "Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00209547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*